In a preclinical study conducted by Dr. Lauren Woodard (Nephrology and Hypertension) and colleagues, stem cells isolated from the urine of healthy donors stimulated regeneration of acutely injured kidney tissue.

The cellular therapy programs at Vanderbilt-Ingram Cancer Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt, and the VA Tennessee Valley Healthcare System have received reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT).

Dr. Harris has been appointed interim chair of the Department of Medicine, effective July 1.

Dr. Kripalani  was elected a Master in Hospital Medicine (MHM) by the Society of Hospital Medicine (SHM) during its recent annual meeting.

Kimberly Dahlman, PhD, associate professor of Medicine in the Division of Hematology and Oncology, will begin serving her three-year term upon the closing of the association’s annual conference on June 17.

John Sergent, MD, Professor of Medicine (Rheumatology and Immunology), who first came to Vanderbilt as an undergraduate student in 1959 and has left an indelible imprint on the University and Medical Center as a student, resident, faculty physician and leader every decade since, is retiring on April 30

Research published in JAMA Dermatology by VUMC investigators, including senior corresponding author Douglas Johnson, MD, MSCI (Hematology and Oncology), provides insight into chronic cirAEs.

Researchers at Vanderbilt University Medical Center, including Milner Staub, MD, MPH (Infectious Diseases), have been awarded a five-year, $4.1 million grant from the National Institutes of Health to assess antibiotic prescriptions and antimicrobial stewardship in unplanned care spaces across Vanderbilt Health.

Vanderbilt University Medical Center has been funded by the Patient-Centered Outcomes Research Institute (PCORI) to implement a team-based, primary care approach to controlling high blood pressure, or hypertension.